21-46125978-G-A

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001849.4(COL6A2):​c.2163G>A​(p.Gln721=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00607 in 1,613,066 control chromosomes in the GnomAD database, including 507 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.032 ( 279 hom., cov: 33)
Exomes 𝑓: 0.0034 ( 228 hom. )

Consequence

COL6A2
NM_001849.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 0.754
Variant links:
Genes affected
COL6A2 (HGNC:2212): (collagen type VI alpha 2 chain) This gene encodes one of the three alpha chains of type VI collagen, a beaded filament collagen found in most connective tissues. The product of this gene contains several domains similar to von Willebrand Factor type A domains. These domains have been shown to bind extracellular matrix proteins, an interaction that explains the importance of this collagen in organizing matrix components. Mutations in this gene are associated with Bethlem myopathy and Ullrich scleroatonic muscular dystrophy. Three transcript variants have been identified for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.6).
BP6
Variant 21-46125978-G-A is Benign according to our data. Variant chr21-46125978-G-A is described in ClinVar as [Benign]. Clinvar id is 93935.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr21-46125978-G-A is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.754 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.106 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
COL6A2NM_001849.4 linkuse as main transcriptc.2163G>A p.Gln721= synonymous_variant 26/28 ENST00000300527.9 NP_001840.3
COL6A2NM_058174.3 linkuse as main transcriptc.2163G>A p.Gln721= synonymous_variant 26/28 ENST00000397763.6 NP_478054.2
COL6A2NM_058175.3 linkuse as main transcriptc.2163G>A p.Gln721= synonymous_variant 26/28 NP_478055.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
COL6A2ENST00000300527.9 linkuse as main transcriptc.2163G>A p.Gln721= synonymous_variant 26/281 NM_001849.4 ENSP00000300527 P1P12110-1
COL6A2ENST00000397763.6 linkuse as main transcriptc.2163G>A p.Gln721= synonymous_variant 26/285 NM_058174.3 ENSP00000380870 P12110-2
COL6A2ENST00000409416.6 linkuse as main transcriptc.2163G>A p.Gln721= synonymous_variant 25/275 ENSP00000387115 P12110-3

Frequencies

GnomAD3 genomes
AF:
0.0315
AC:
4798
AN:
152124
Hom.:
279
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.108
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0139
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000621
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.000456
Gnomad OTH
AF:
0.0301
GnomAD3 exomes
AF:
0.00835
AC:
2097
AN:
251102
Hom.:
99
AF XY:
0.00622
AC XY:
845
AN XY:
135850
show subpopulations
Gnomad AFR exome
AF:
0.108
Gnomad AMR exome
AF:
0.00697
Gnomad ASJ exome
AF:
0.0000994
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000229
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000617
Gnomad OTH exome
AF:
0.00375
GnomAD4 exome
AF:
0.00342
AC:
4996
AN:
1460824
Hom.:
228
Cov.:
78
AF XY:
0.00297
AC XY:
2155
AN XY:
726696
show subpopulations
Gnomad4 AFR exome
AF:
0.112
Gnomad4 AMR exome
AF:
0.00823
Gnomad4 ASJ exome
AF:
0.0000765
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000174
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000347
Gnomad4 OTH exome
AF:
0.00744
GnomAD4 genome
AF:
0.0315
AC:
4803
AN:
152242
Hom.:
279
Cov.:
33
AF XY:
0.0298
AC XY:
2222
AN XY:
74442
show subpopulations
Gnomad4 AFR
AF:
0.108
Gnomad4 AMR
AF:
0.0139
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000414
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000456
Gnomad4 OTH
AF:
0.0298
Alfa
AF:
0.0161
Hom.:
54
Bravo
AF:
0.0365
Asia WGS
AF:
0.00635
AC:
22
AN:
3478
EpiCase
AF:
0.00104
EpiControl
AF:
0.000652

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Benign, criteria provided, single submitterclinical testingGeneDxMay 04, 2016This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Likely benign, no assertion criteria providedclinical testingGenetic Services Laboratory, University of Chicago-Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Jul 17, 2012- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
not provided Benign:3
Likely benign, no assertion criteria providedclinical testingLaboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)-- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsDec 20, 2017- -
Myosclerosis Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -
Bethlem myopathy 1A Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 28, 2024- -
Collagen 6-related myopathy Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.60
CADD
Benign
7.3
DANN
Benign
0.73

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs16978875; hg19: chr21-47545892; API